Current Therapies in Kidney Transplant Rejection
This review paper synthesizes current therapies for kidney transplant rejection, noting that while various treatments exist for both T-cell and antibody-mediated rejection, the efficacy of many, particularly for antibody-mediated rejection, remains questionable due to a lack of high-quality randomized controlled trials. It underscores that rejection continues to significantly impact long-term graft survival, emphasizing the critical need for further research into more effective strategies.